Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery

被引:95
作者
Corriu, C
Feletou, M
Canet, E
Vanhoutte, PM
机构
[1] INST RECH SERVIER,DEPT PNEUMOL,F-92150 SURESNES,FRANCE
[2] INST RECH INT SERVIER,F-92410 COURBEVOIE,FRANCE
关键词
EDHF; endothelium; hyperpolarization; electrophysiology; cytochrome P450; clotrimazble; SKF525a; metyrapone; quinacrine; smooth muscle cells;
D O I
10.1111/j.1476-5381.1996.tb15233.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Transmembrane potentials were recorded from isolated carotid arteries of the guinea-pig superfused with modified Krebs-Ringer bicarbonate solution. Smooth muscle cells were impaled with sharp intracellular microelectrodes. 2 Acetylcholine (1 mu M) induced an endothelium-dependent hyperpolarization (14.3 +/- 2.8 mV, n = 6) which was not affected (15.1 +/- 1.1 mV, n = 35) by inhibitors of cyclo-oxygenase (indomethacin, 5 mu M) and nitric oxide synthase (N(w)nitro-L-arginine:L-NOARG, 100 mu M). 3 The hyperpolarization produced by acetylcholine was abolished in the presence of elevated potassium (35 mM) in the superfusing physiological saline solution. 4 The acetylcholine-induced hyperpolarization was not affected by the inhibitors of cytochrome P450 mono-oxygenases, SKF525a (10 and 100 mu M, 13.9 +/- 2.2 and 15.3 +/- 4.6 mV), metyrapone (100 mu M, 13.1 +/- 1.9 mV), clotrimazole (100 mu M, 13.5 +/- 2.7 mV), 17-octadecynoic acid (5 mu M, 16.5 +/- 1.9 mV), methoxsalen (10 mu M, 15.3 +/- 1.6 mV), the inhibitor of phospholipase A(2) quinacrine (10 mu M 12.8 +/- 2.5 mV) and the non specific lipoxygenases/cyclo-oxygenases/cytochrome P450 inhibitor, eicosatetraynoic acid (50 mu M, 15.0 +/- 2.2 mV). However, the muscarinic antagonist, atropine (100 nM), abolished the hyperpolarization. 5 These results suggest that in guinea-pig carotid artery, the metabolism of arachidonic acid, either through cyclo-oxygenase, lipoxygenase or cytochrome p450 mono-oxygenase, is not involved in acetylcholine-induced endothelium-dependent hyperpolarizations.
引用
收藏
页码:607 / 610
页数:4
相关论文
共 18 条
[1]   DISPLAY OF THE CHARACTERISTICS OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR BY A CYTOCHROME P450-DERIVED ARACHIDONIC-ACID METABOLITE IN THE CORONARY MICROCIRCULATION [J].
BAUERSACHS, J ;
HECKER, M ;
BUSSE, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1548-1553
[2]   HYPERPOLARIZATION OF ARTERIAL SMOOTH-MUSCLE INDUCED BY ENDOTHELIAL HUMORAL SUBSTANCES [J].
CHEN, G ;
YAMAMOTO, Y ;
MIWA, K ;
SUZUKI, H .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (06) :H1888-H1892
[3]   ACETYLCHOLINE RELEASES ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AND EDRF FROM RAT-BLOOD VESSELS [J].
CHEN, G ;
SUZUKI, H ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1165-1174
[4]   ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION OF CANINE CORONARY SMOOTH-MUSCLE [J].
FELETOU, M ;
VANHOUTTE, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (03) :515-524
[5]   CYTOCHROME P450-DEPENDENT EFFECTS OF BRADYKININ IN THE RAT-HEART [J].
FULTON, D ;
MAHBOUBI, K ;
MCGIFF, JC ;
QUILLEY, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) :99-102
[6]   ENDOTHELIUM-DERIVED RELAXING AND CONTRACTING FACTORS [J].
FURCHGOTT, RF ;
VANHOUTTE, PM .
FASEB JOURNAL, 1989, 3 (09) :2007-2018
[7]   MECHANISM OF ACTION OF CEREBRAL EPOXYEICOSATRIENOIC ACIDS ON CEREBRAL ARTERIAL SMOOTH-MUSCLE [J].
GEBREMEDHIN, D ;
MA, YH ;
FALCK, JR ;
ROMAN, RJ ;
VANROLLINS, M ;
HARDER, DR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (02) :H519-H525
[8]   ROLE OF CYTOCHROME-P-450 ENZYMES AND METABOLITES OF ARACHIDONIC-ACID IN THE CONTROL OF VASCULAR TONE [J].
HARDER, DR ;
CAMPBELL, WB ;
ROMAN, RJ .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (02) :79-92
[9]   CHARACTERIZATION OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AS A CYTOCHROME P450-DERIVED ARACHIDONIC-ACID METABOLITE IN MAMMALS [J].
HECKER, M ;
BARA, AT ;
BAUERSACHS, J ;
BUSSE, R .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 481 (02) :407-414
[10]   ACTIVATION OF K+-CHANNEL IN VASCULAR SMOOTH MUSCLES BY CYTOCHROME-P450 METABOLITES OF ARACHIDONIC-ACID [J].
HU, SL ;
KIM, HS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (02) :215-221